Below is a recap of research funding opportunitiesthat were recently announced, nationwide. While these alerts are intended to provide you with a broad-reaching overview of the opportunities available, we certainly want to hear if thereare specific opportunities that you would like to pursue. Please let your Content Director know if you have any questions or are interested in learning more.
In addition, Hanover is closely monitoring developments surrounding COVID-19. As always, ourCOVID Grant Alerts dashboard profiles all relevant previously announced national-level COVID-19 funding opportunities, which can be sorted by type, agency/funder, and date.
Finally, your dedicated Content Director and Relationship Director also are ready to help with custom research solutions to the challenges you are facing.
Quick Links to Opportunities
These links will take you directly to the websites of the grant opportunities.
NIOSH has established surveillance programs intended to assess the extent and severity of workplace illnesses, injuries, exposures, and fatalities; identify workers and occupations at greatest risk; set program priorities for follow-up activities, including more in-depth data surveillance and outreach, prevention and/or intervention programs and policies to address state priorities and emerging issues; develop a broad network of partners who can assist in identifying occupational safety and health surveillance data and best ways to disseminate results to stakeholders; communicate audience-specific educational materials and other resources for optimizing their uptake and adoption for protecting workers; and measure the effectiveness of prevention activities.
Eligibility:
There are no eligibility restrictions.
Dates:
LOIs are due by October 30, 2020; proposals are due by December 16, 2020 (with similar dates through 2022).
This program intends to advance our understanding of: the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8); the biology of the initial steps of infection; and the risk factors for infection. Such studies should inform and advance efforts to reduce or eliminate KSHV transmission and thus prevent Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and other KSHV-induced diseases in populations living with HIV or at high risk of HIV infection.
Eligibility
There are no eligibility restrictions.
Dates:
LOIs are due by November 15, 2020, with full proposals due by December 15, 2020 (with similar dates in 2021).
This program invites multiple-PD/PI applications for collaborative research projects each with two to three independent modeling groups that will comprise a new “incubator” program within the Cancer Intervention and Surveillance Modeling Network (CISNET). The overarching goal of this FOA is to expand comparative simulation modeling approaches developed by CISNET to new cancer organ sites beyond the sites which have been previously funded (breast, colorectal, prostate, lung, esophageal, and cervical) under CISNET. Up to four grants will be awarded.
Eligibility:
There are no eligibility restrictions.
Dates:
LOIs are due by December 20, 2020, with full proposals due by January 20, 2021.
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities related to NIAID's mission areas with a primary focus on: Courses for Skills Development; Research Experiences and Mentoring Activities.
Eligibility:
There are no eligibility restrictions.
Dates:
LOIs are due by November 7, 2020, with full proposals due by December 7, 2020.
This program is intended to support the development of technologies, production efforts, and dissemination resources for a cell type-specific armamentarium to study brain function across species. The goal is to promote evaluation of molecular or genetic technologies and creation of pilot production and distribution resources for cell type-specific access and manipulation reagents for several vertebrate species, including in human ex vivo tissues or cells.
Eligibility:
There are no eligibility restrictions.
Dates:
LOIs are due by January 11, 2021, with full proposals due by February 11, 2021 (there is also another deadline in late 2021).
The purpose of this program is to support intramural-extramural collaborations on late-stage translational science projects between NCATS Therapeutic Development Branch and extramural researchers, for therapeutic development of small molecules, biologics, or gene therapies.
Eligibility:
There are no eligibility restrictions.
Dates:
LOIs are due by January 9, 2021, with full proposals due by February 9, 2021 (with similar dates through 2023).
This program seeks to solicit applications focused on the anticipated development and implementation of U.S. regional strategies through recipient-developed and coalition-led efforts for multiple U.S. basins that will enable the realization of the full economic potential of producing Rare Earth Elements, Critical Minerals, and high-value, nonfuel, Carbon-Based Products from coal. There will be eight grants of roughly $23 million each.
Eligibility:
Coalitions will be multi-faceted and include coal mining companies, regional private industries, universities, training and workforce development organizations, National Laboratories, state, local and federal agencies, and non-profit/non-governmental stakeholders, to facilitate the establishment of public-private innovation centers to incubate innovated mining, beneficiation, processing and purification technologies.
The purpose of the Research on Emerging Technologies for Teaching and Learning program is to fund exploratory and synergistic research in emerging technologies (to include, but not limited to, artificial intelligence, robotics, and immersive or augmenting technologies) for teaching and learning in the future. The program accepts proposals that focus on learning, teaching, or a combination of both. The scope of the program is broad, with special interest in diverse learner/educator populations, contexts, and content, including teaching and learning in STEM and in foundational areas that enable STEM (e.g., self-regulation, literacy, communication, collaboration, creativity, and socio-emotional skills).
Eligibility:
There are no eligibility restrictions.
Dates:
Proposals are due by January 25, 2021 (with similar dates through late 2022).
The Collaborative Research program aims to advance humanistic knowledge through sustained collaboration between two or more scholars. Collaborators may be drawn from a single institution or several institutions across the United States; up to half of the collaborators may be based outside of the U.S. The program encourages projects that propose diverse approaches to topics, incorporate multiple points of view, and explore new avenues of inquiry in the humanities.
The Foundation for a Smoke-free World seeks to conduct research at the nexus of COVID-19, smoking, and nicotine that requires significant collaboration and research involving outside experts and organizations. Grantees will be expected to implement a range of projects relevant to the global pandemic, including well-designed and comprehensive pre-clinical, clinical, and epidemiological studies, to better understand the associations between smoking and/or nicotine use, and COVID-19 infection and outcomes. Grants are up to $500,000.
The Alzheimer’s Drug Discovery Foundation welcomes Letters of Intent for its Neuroimaging and CSF Biomarker Development Program. Grants of up to $600,000 will be awarded in support of the advancement of neuroimaging and CSF biomarkers that can do one or more of the following: Demonstrate Target Engagement for Novel Therapeutics; Detect Signs of Disease Earlier and Monitor Progression; and More Accurately Diagnose and Distinguish Between Dementia Subtypes.
The Kenneth Rainin Foundation has announced that it is opening its annual Innovator Awards to meet researcher needs. The program supports scientists worldwide who embrace novel, untested ideas with the potential to advance the study of Inflammatory Bowel Disease. The awards program will provide grants of up to $150,000 in support of one-year research projects.
The National Geographic Society and Microsoft’s AI for Earth program have issued an RFP for novel projects that create and deploy AI tools to improve the way we monitor, model, understand, and ultimately manage Earth’s natural systems for a more sustainable future. Under the AI for Earth Innovation RFP, grants of up to $100,000 will be awarded in support of projects that use cloud computing to create and deploy open source trained models and algorithms that make key analytical processes more efficient in the environmental field.
The foundation is inviting applications for research with the potential to improve services and systems and increase positive social and physical conditions through policy development, the placement and shaping of the policy agenda, policy adoption or implementation, policy blocking, advocacy, the shaping of public sentiment, and challenges related to language and literacy. Grants are up to $20,000.
Eligibility:
There are no eligibility restrictions.
Dates:
Concept proposals are due by October 15, 2020.
Questions?
We'll be happy to help you find the right grants opportunity for your organization.
CONNECT WITH US
About Hanover Research: Founded in 2003, Hanover Research is a global research and grant development firm. The Hanover Grants practice provides research development, grant writing, and strategic advising support to a wide range of institutions and organizations. Our professionals deliver customized proposal review, revision, and production support, while also helping to align strategic priorities to funding trends and opportunities at all levels. To learn more about Hanover Research, visit www.hanoverresearch.com.
Hanover Research, LLC 4401 Wilson Blvd, 9th Floor Arlington VA 22203
You received this email because you are subscribed to Grant Alerts and Calendars from Hanover Research, LLC.
Update your email preferences to choose the types of emails you receive.
